Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

Lenovo Group Limited is a multinational technology company specializing in designing, manufacturing, and marketing consumer electronics, personal computers, software, servers, and related services. Its key products include laptops (ThinkPad, IdeaPad, Yoga, Legion), desktop computers, smartphones (Motorola Mobility), and IT infrastructure solutions. The company was founded on November 1, 1984, in Beijing, China, and has global headquarters in Beijing, China, and Morrisville, North Carolina, United States.

<ul>
 <li>
Global Scale and PC Market Dominance: <a href="https://smartkarma.com/entities/lenovo-group-limited">Lenovo</a> Group Limited (992 HK) holds the leading global PC market share of approximately 23-24%, creating a wide manufacturing and procurement scale advantage. The company is positioned to capitalize on the multi-year AI PC upgrade cycle across both commercial and consumer enterprise markets.</li>
 <li>
Diversification into Enterprise AI and Services: The company's strategic rotation toward its Infrastructure Solutions Group (ISG) and Solutions and Services Group (SSG) is expanding higher-margin recurring revenues, driven by enterprise AI server architectures, proprietary Neptune direct liquid-cooling solutions, and TruScale as-a-service contracts.</li>
 <li>
Financial Trajectory and Capital Discipline: <a href="https://smartkarma.com/entities/lenovo-group-limited">Lenovo</a> delivered three-year revenue CAGR of 10.11% and free cash flow CAGR of 16.48% through FY2026, reaching HK$648.3B in revenue. While gross margins remain disciplined near 15-16%, quarterly bottom-line lumpiness—such as the net loss recorded in the quarter ended June 2026—underscores the need to manage component cost fluctuations and aggressive hyperscale infrastructure pricing.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  
Global Scale and PC Market Dominance: Lenovo Group Limited (992 HK) holds the leading global PC market share of approximately 23-24%, creating a wide manufacturing and procurement scale advantage. The company is positioned to capitalize on the multi-year AI PC upgrade cycle across both commercial and consumer enterprise markets.
  
Diversification into Enterprise AI and Services: The company's strategic rotation toward its Infrastructure Solutions Group (ISG) and Solutions and Services Group (SSG) is expanding higher-margin recurring revenues, driven by enterprise AI server architectures, proprietary Neptune direct liquid-cooling solutions, and TruScale as-a-service contracts.
  
Financial Trajectory and Capital Discipline: Lenovo delivered three-year revenue CAGR of 10.11% and free cash flow CAGR of 16.48% through FY2026, reaching HK$648.3B in revenue. While gross margins remain disciplined near 15-16%, quarterly bottom-line lumpiness—such as the net loss recorded in the quarter ended June 2026—underscores the need to manage component cost fluctuations and aggressive hyperscale infrastructure pricing.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Quality-first, Business-perspective, Long-term, Urbem (HK) Limited

Urbem Capital

Quality-first, Business-perspective, Long-term

Quality-first, Business-perspective Strategy

Urbem (HK) Limited

Perfect Medical Health Management / Equity Bottom-Up

Perfect Medical Health Management is an investment holding company primarily engaged in providing medical health and medical beauty services. The company offers a comprehensive range of non-invasive medical and aesthetic services, including personalized medical aesthetic solutions, hair growth treatments, pain management, preventive care, and reproductive medical services. It operates across Hong Kong, Macau, Mainland China, Australia, and Singapore. The company was incorporated on March 11, 2011, and is headquartered in Hong Kong.

Perfect Medical Health Management (1830 HK)

<ul>
<li>Low growth, high return: revenue barely grew in a decade, yet IPO subscribers who kept the cash earned about 19% a year.</li>
<li>Benchmark beaten handsomely: Hong Kong’s market index returned 3.5% a year, and an index portfolio paying the same dividends would have run dry in 2020.</li>
<li>The engine was allocation, not growth: a capital-light, prepaid business paid out at least 100% of profit for eleven years, yet later buyers who overpaid still lost.</li>
</ul>


Low growth, high return: revenue barely grew in a decade, yet IPO subscribers who kept the cash earned about 19% a year.
Benchmark beaten handsomely: Hong Kong’s market index returned 3.5% a year, and an index portfolio paying the same dividends would have run dry in 2020.
The engine was allocation, not growth: a capital-light, prepaid business paid out at least 100% of profit for eleven years, yet later buyers who overpaid still lost.


Perfect Medical: How a Low-Growth Company Beat the Market by Paying Out Everything

Research from Quam Securities, Quam Securities

Quam Securities Research

Research from Quam Securities

Quam Securities

Since its inception in 1986, Quam Securities Limited (Quam Securities) has grown to become one of the few mid-tier securities brokerages in Hong Kong with global execution capabilities for both private and institutional clients. It boasts a well-established network in Greater China including Taiwan and in major world markets through the Global Alliance Partners (GAP). Quam Securities is well-positioned not only to harness and drive business within the China Tonghai International Financial Limited but also between China and the world markets.

Cross Asset Strategy

<ul><li>Affected by external market sentiment, the HSI opened down 62 pts in the morning and at one point dropped by more than 200 pts in early trading.</li><li>Asian chipmakers rebounded following heavy losses, although concerns over AI valuations, Chinese semiconductor competition and the returns on AI infrastructure spending persisted.</li><li>Producer price inflation climbed to 5.0% from 3.8%, its strongest increase since June 2022, as renewed Middle East hostilities and risks to global oil supplies drove up input costs and squeezed corporate margins.</li></ul>

Affected by external market sentiment, the HSI opened down 62 pts in the morning and at one point dropped by more than 200 pts in early trading.Asian chipmakers rebounded following heavy losses, although concerns over AI valuations, Chinese semiconductor competition and the returns on AI infrastructure spending persisted.Producer price inflation climbed to 5.0% from 3.8%, its strongest increase since June 2022, as renewed Middle East hostilities and risks to global oil supplies drove up input costs and squeezed corporate margins.

Asian Hedge Fund Manager, Long Short Equity, Macro

David Mudd

<ul>
<li>HK Alpha portfolio gained 2.22% in September, outperforming its benchmark by 5.36%. Since inception, the portfolio has outperformed HK indexes by 66% to 93%. HK ALPHA is up 14.35% YTD.</li>
<li>The Sharpe ratio stands at 1.22, compared with a benchmark of 0.56 since inception. This higher Sharpe ratio is driven by excess alpha, which represents more than 50% of returns.</li>
<li>The portfolio gained in the healthcare and energy sectors in August, while exposure to materials and communication services dragged on performance.</li>
</ul>


HK Alpha portfolio gained 2.22% in September, outperforming its benchmark by 5.36%. Since inception, the portfolio has outperformed HK indexes by 66% to 93%. HK ALPHA is up 14.35% YTD.
The Sharpe ratio stands at 1.22, compared with a benchmark of 0.56 since inception. This higher Sharpe ratio is driven by excess alpha, which represents more than 50% of returns.
The portfolio gained in the healthcare and energy sectors in August, while exposure to materials and communication services dragged on performance.


HONG KONG ALPHA PORTFOLIO: (September 2026)

Equity, Bottom-up Analyst, Investics Research

Sameer Taneja

Equity, Bottom-up Analyst

Investics Research

It is important to note that the information provided by Investics Research is based on publicly available data and own knowledge, which has been gathered and analyzed from a variety of sources. While every effort has been made to ensure the accuracy and completeness of the information provided, it is not guaranteed to be free from errors or omissions. All forecasts and estimates are based on information that has been obtained from public sources that are considered to be reliable. The sources include but are not limited to, company announcements, exchange filings, presentations, etc. Investics does not guarantee the accuracy and completeness of the forecasts, estimates, and/or other information.

Equity Bottom-up Research

Oriental Watch is an investment holding company primarily engaged in the trading of watches and clocks through an extensive retail network in Greater China. It sells watches from numerous prestigious brands, including Rolex, Tudor, Bulgari, Breitling, and Longines. The company also engages in property holding and securities investment activities. Headquartered in Central, Hong Kong, the company was founded in 1961.

<ul>
<li>This is a part of our series <a href="https://www.smartkarma.com/insights/timeless-a-follow-up-on-the-luxury-watch-retailer-space-and-their-impressive-capital-allocation" target="_blank" data-smartkarma-citation="insights:267136" rel="noopener">Timeless: A Follow-Up on the Luxury Watch Retailer Space and Their Impressive Capital Allocation</a>/ <a href="https://www.smartkarma.com/insights/ticking-different-a-comparison-of-the-world-s-listed-luxury-watch-retailers-with-exposure-to-rolex" target="_blank" data-smartkarma-citation="insights:241854" rel="noopener">Ticking Different: A Comparison of the Rolex Watch Retailers </a>
</li>
<li>We expect <a href="https://www.smartkarma.com/entities/oriental-watch-holdings-limited" target="_blank" data-smartkarma-citation="entities:19950:1" rel="noopener">Oriental Watch (398 HK)</a> to show 10-15% YoY earnings growth in its H1FY27 results, to be declared in November (this is a March-end company). </li>
<li>With a 100% payout, we expect a dividend of 23.5 HKD cents (47 HKD cents annualized, or a 14.6% dividend yield), with 62% of the market cap in net cash. </li>
</ul>


This is a part of our series Timeless: A Follow-Up on the Luxury Watch Retailer Space and Their Impressive Capital Allocation/ Ticking Different: A Comparison of the Rolex Watch Retailers 

We expect Oriental Watch (398 HK) to show 10-15% YoY earnings growth in its H1FY27 results, to be declared in November (this is a March-end company). 
With a 100% payout, we expect a dividend of 23.5 HKD cents (47 HKD cents annualized, or a 14.6% dividend yield), with 62% of the market cap in net cash. 


Oriental Watch (398 HK): Previewing Earnings For H1FY27